raloxifene has been researched along with Central Nervous System Disease in 1 studies
raloxifene : A member of the class of 1-benzothiophenes that is 1-benzothiophene in which the hydrogens at positions 2, 3, and 6 have been replaced by p-hydroxyphenyl, p-[2-(piperidin-1-yl)ethoxy]benzoyl, and hydroxy groups, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schopfer, U | 1 |
| Schoeffter, P | 1 |
| Bischoff, SF | 1 |
| Nozulak, J | 1 |
| Feuerbach, D | 1 |
| Floersheim, P | 1 |
1 other study available for raloxifene and Central Nervous System Disease
| Article | Year |
|---|---|
Toward selective ERbeta agonists for central nervous system disorders: synthesis and characterization of aryl benzthiophenes.
Topics: Amino Acid Motifs; Binding Sites; Central Nervous System Diseases; Crystallography, X-Ray; Estrogen | 2002 |